Rick Falzone
About
In The Last Decade
Rick Falzone
10 papers receiving 98 citations
Peers
Comparison fields: 5 of 35
- Molecular Biology 78
- Cancer Research 27
- Biomaterials 15
- Nephrology 11
- Epidemiology 8
Countries citing papers authored by Rick Falzone
This map shows the geographic impact of Rick Falzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Falzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Falzone more than expected).
Fields of papers citing papers by Rick Falzone
This network shows the impact of papers produced by Rick Falzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Falzone. The network helps show where Rick Falzone may publish in the future.
Co-authorship network of co-authors of Rick Falzone
This figure shows the co-authorship network connecting the top 25 collaborators of Rick Falzone. A scholar is included among the top collaborators of Rick Falzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Falzone. Rick Falzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy | 2 |
| 5 | 15 | |
| 6 | 7 | |
| 7 | ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis | 1 |
| 8 | 44 | |
| 9 | 7 | |
| 10 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.